Prosecution Insights
Last updated: May 29, 2026

Examiner: LYONS, MARY M

Tech Center 1600 • Art Units: 1600 1645 1651 1653

This examiner grants 66% of resolved cases

Performance Statistics

65.5%
Allow Rate
+5.5% vs TC avg
618
Total Applications
+41.5%
Interview Lift
1076
Avg Prosecution Days
Based on 568 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
20.0%
§102 Novelty
42.7%
§103 Obviousness
15.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17756627 NOVEL BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE VARIANT AND METHOD FOR PRODUCING LEUCINE USING THE SAME Final Rejection CJ CHEILJEDANG CORPORATION
18014220 METHOD FOR ANTIGEN DETECTION FROM DIRECT CLINICAL SAMPLES Non-Final OA The Regents of the University of California
17786127 DECREASING TOXICITY OF TERPENES AND INCREASING THE PRODUCTION POTENTIAL IN MICRO-ORGANISMS Final Rejection BASF SE
18284680 NEISSERIA GONORRHOEAE DETECTION KIT AND NEISSERIA GONORRHOEAE DETECTION METHOD Non-Final OA ASAHI KASEI KABUSHIKI KAISHA
18344773 PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION Non-Final OA Clara Foods Co.
18014236 MULTISPECIFIC CORONAVIRUS ANTIBODIES Non-Final OA Dana-Farber Cancer Institute, Inc.
17673581 COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME Non-Final OA MarvelBiome, Inc.
17689117 METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY Final Rejection The General Hospital Corporation
18569535 BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BLA36 FOR RELIEVING CONSTIPATION, METHOD FOR CULTURING SAME, AND USE THEREOF Non-Final OA WECARE PROBIOTICS CO., LTD.
18286005 ENCAPSULATED MICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME Non-Final OA Monsanto Technology LLC
18273796 BLUE-GREEN ALGAE-CONTAINING TABLET Final Rejection DIC Corporation
18024647 ENGINEERED ORAL BACTERIA AND USES THEREOF Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
17895245 METHODS AND COMPOSITIONS FOR DOCKING BIOTINYLATED ANTIGENS ON THE EXTERIOR OF BACTERIAL OUTER MEMBRANE VESICLES Final Rejection CORNELL UNIVERSITY
18265694 COSMETIC, NUTRACEUTICAL OR DERMATOLOGICAL USE OF A LACTOBACILLUS CRISPATUS STRAIN AND/OR OF A COMPOSITION COMPRISING SAME Final Rejection BASF Corporation
17125555 STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF Final Rejection Pfizer Inc.
17540823 BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY Non-Final OA Spogen Biotech Inc.
17310450 METHODS FOR IDENTIFYING MICROBIAL STRAINS HAVING ENHANCED PLANT COLONIZATION EFFICIENCY Non-Final OA NewLeaf Symbiotics, Inc.
17255270 SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM Final Rejection NEWLEAF SYMBIOTICS, INC.
18010677 Means and Methods to Improve Yeast Fermentation Efficiency Non-Final OA KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D
18005204 DUAL FUNCTION SURFACE FOR CELL CAPTURE AND SPREADING Non-Final OA UNIVERSITÉ LAVAL
18554108 COMPOSITION FOR INHIBITING BIOFILM COMPRISING LACTOBACILLUS RHAMNOSUS AS ACTIVE INGREDIENT Final Rejection Chr. Hansen A/S
18052595 PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSES Non-Final OA Conagen Inc.
18285480 NEW YEAST STRAIN AND ITS USES FOR THE CONTROL OF PHYTOPATHOGENS Non-Final OA AGROVENTURES LLC
17791038 Vaccines targeting Neisseria gonorrhoeae Final Rejection Evaxion Biotech A/S
18265400 METHOD FOR CONSTRUCTING STRICTLY ANAEROBIC SALMONELLA, CONSTRUCTED STRICTLY ANAEROBIC SALMONELLA AND APPLICATION THEREOF Non-Final OA SHENZHEN SYNTHETICA PIONEERING CO., LTD.
18040362 Materials and Methods for Improving Plant Health Non-Final OA RWTH AACHEN
18007317 EXPRESSION HOST Non-Final OA BIOTALYS NV
18157127 Increased Lipid Production Through Metabolic Activation With Ionizing Radiation Non-Final OA Varicon Aqua Solutions Ltd.
18011479 AGRICULTURALLY BENEFICIAL MICROBES, MICROBIAL COMPOSITIONS, AND CONSORTIA Non-Final OA BioConsortia, Inc.
18060831 MICROBIAL CONSORTIA Final Rejection Federation Bio, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month